2021 Q1 Form 10-Q Financial Statement
#000156459021026054 Filed on May 10, 2021
Income Statement
Concept | 2021 Q1 | 2020 Q1 |
---|---|---|
Revenue | $10.13M | $11.55M |
YoY Change | -12.26% | -12.3% |
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $6.670M | $5.170M |
YoY Change | 29.01% | 113.64% |
% of Gross Profit | ||
Research & Development | $40.86M | $27.46M |
YoY Change | 48.81% | 29.6% |
% of Gross Profit | ||
Depreciation & Amortization | $671.0K | $632.0K |
YoY Change | 6.17% | 20.15% |
% of Gross Profit | ||
Operating Expenses | $47.53M | $32.63M |
YoY Change | 45.67% | 38.24% |
Operating Profit | -$37.40M | -$21.08M |
YoY Change | 77.39% | 102.01% |
Interest Expense | $12.00K | $21.00K |
YoY Change | -42.86% | -93.23% |
% of Operating Profit | ||
Other Income/Expense, Net | $221.0K | $888.0K |
YoY Change | -75.11% | 191.15% |
Pretax Income | -$37.18M | -$20.19M |
YoY Change | 84.09% | 99.33% |
Income Tax | $0.00 | -$675.0K |
% Of Pretax Income | ||
Net Earnings | -$37.18M | -$19.52M |
YoY Change | 90.46% | 92.67% |
Net Earnings / Revenue | -366.95% | -169.05% |
Basic Earnings Per Share | ||
Diluted Earnings Per Share | -$528.0K | -$330.8K |
COMMON SHARES | ||
Basic Shares Outstanding | 73.38M | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2021 Q1 | 2020 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $681.6M | $347.9M |
YoY Change | 95.92% | |
Cash & Equivalents | $351.6M | $182.7M |
Short-Term Investments | $330.0M | $165.3M |
Other Short-Term Assets | $8.200M | $5.700M |
YoY Change | 43.86% | |
Inventory | ||
Prepaid Expenses | ||
Receivables | $7.600M | |
Other Receivables | $0.00 | |
Total Short-Term Assets | $697.4M | $362.1M |
YoY Change | 92.6% | |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $37.60M | $15.20M |
YoY Change | 147.37% | |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $1.400M | $700.0K |
YoY Change | 100.0% | |
Total Long-Term Assets | $114.3M | $92.20M |
YoY Change | 23.97% | |
TOTAL ASSETS | ||
Total Short-Term Assets | $697.4M | $362.1M |
Total Long-Term Assets | $114.3M | $92.20M |
Total Assets | $811.7M | $454.3M |
YoY Change | 78.67% | |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $9.700M | $7.900M |
YoY Change | 22.78% | |
Accrued Expenses | $24.00M | $16.40M |
YoY Change | 46.34% | |
Deferred Revenue | $9.964M | |
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $200.0K | |
YoY Change | ||
Total Short-Term Liabilities | $43.76M | $41.50M |
YoY Change | 5.44% | |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $1.439M | $20.40M |
YoY Change | -92.95% | |
Total Long-Term Liabilities | $1.439M | $20.40M |
YoY Change | -92.95% | |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $43.76M | $41.50M |
Total Long-Term Liabilities | $1.439M | $20.40M |
Total Liabilities | $89.07M | $69.00M |
YoY Change | 29.09% | |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$302.7M | |
YoY Change | ||
Common Stock | $1.025B | |
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $722.6M | $385.3M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $811.7M | $454.3M |
YoY Change | 78.66% |
Cashflow Statement
Concept | 2021 Q1 | 2020 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$37.18M | -$19.52M |
YoY Change | 90.46% | 92.67% |
Depreciation, Depletion And Amortization | $671.0K | $632.0K |
YoY Change | 6.17% | 20.15% |
Cash From Operating Activities | -$37.25M | -$28.02M |
YoY Change | 32.94% | 122.28% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $3.579M | $603.0K |
YoY Change | 493.53% | 76.83% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $5.890M | -$59.11M |
YoY Change | -109.96% | -1069.02% |
Cash From Investing Activities | $2.309M | -$59.72M |
YoY Change | -103.87% | -1136.56% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | $281.7M | $253.7M |
YoY Change | 11.03% | 1812164.29% |
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 282.3M | 253.7M |
YoY Change | 11.24% | 1812357.14% |
NET CHANGE | ||
Cash From Operating Activities | -37.25M | -28.02M |
Cash From Investing Activities | 2.309M | -59.72M |
Cash From Financing Activities | 282.3M | 253.7M |
Net Change In Cash | 247.3M | 166.0M |
YoY Change | 48.98% | -2530.6% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$37.25M | -$28.02M |
Capital Expenditures | $3.579M | $603.0K |
Free Cash Flow | -$40.83M | -$28.62M |
YoY Change | 42.64% | 121.08% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2020Q4 | rvmd |
Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
|
18784000 | |
CY2021Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
28294000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
28992000 | |
CY2021Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1439000 | |
CY2020Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
632000 | |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
92725000 | |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
10131000 | |
CY2020Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
11546000 | |
CY2021Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
40858000 | |
CY2020Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
27457000 | |
CY2021Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
6670000 | |
CY2020Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
27435000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
8481000 | |
CY2021Q1 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
7564000 | |
CY2021Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2020Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
60945000 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2020Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
305000 | |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
47176000 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2020Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
1084000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3672000 | |
CY2020Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
6393000 | |
CY2021Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3700000 | |
CY2020Q4 | us-gaap |
Goodwill
Goodwill
|
14608000 | |
CY2020Q4 | us-gaap |
Assets
Assets
|
567401000 | |
CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
12609000 | |
CY2021Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
9964000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
12111000 | |
CY2021Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
43759000 | |
CY2021Q1 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
8135000 | |
CY2020Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
7444000 | |
CY2021Q1 | us-gaap |
Liabilities
Liabilities
|
89071000 | |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | |
CY2020Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
116000 | |
CY2021Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
8000 | |
CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
7000 | |
CY2021Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-302721000 | |
CY2021Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1025230000 | |
CY2020Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
740098000 | |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
722580000 | |
CY2021Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
63000 | |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-265545000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
474676000 | |
CY2021Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
811651000 | |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
567401000 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | |
CY2021Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
73435109 | |
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
66599748 | |
CY2021Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
73435109 | |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
66599748 | |
CY2020Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5171000 | |
CY2021Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
47528000 | |
CY2020Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
32628000 | |
CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-37397000 | |
CY2020Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-21082000 | |
CY2021Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
233000 | |
CY2020Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
909000 | |
CY2021Q1 | us-gaap |
Interest Expense
InterestExpense
|
12000 | |
CY2020Q1 | us-gaap |
Interest Expense
InterestExpense
|
21000 | |
CY2021Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
221000 | |
CY2020Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
888000 | |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-37176000 | |
CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-20194000 | |
CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-675000 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-37176000 | |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-19519000 | |
CY2020Q1 | rvmd |
Redeemable Convertible Preferred Stock Dividends Undeclared And Cumulative
RedeemableConvertiblePreferredStockDividendsUndeclaredAndCumulative
|
2219000 | |
CY2021Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-37176000 | |
CY2020Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-21738000 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.53 | |
CY2020Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.74 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
70420076 | |
CY2020Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
29297698 | |
CY2021Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-53000 | |
CY2020Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-38000 | |
CY2021Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-37229000 | |
CY2020Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-19557000 | |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
555000 | |
CY2021Q1 | rvmd |
Adjustments To Additional Paid In Capital Vesting Of Early Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExerciseOfStockOptions
|
46000 | |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3387000 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-152574000 | |
CY2020Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
305109000 | |
CY2020Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
27000 | |
CY2020Q1 | rvmd |
Adjustments To Additional Paid In Capital Vesting Of Early Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExerciseOfStockOptions
|
47000 | |
CY2020Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1567000 | |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
385316000 | |
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-37176000 | |
CY2020Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-19519000 | |
CY2021Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
267000 | |
CY2020Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
267000 | |
CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3387000 | |
CY2020Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1567000 | |
CY2021Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
671000 | |
CY2020Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
632000 | |
CY2021Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-534000 | |
CY2020Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
105000 | |
CY2021Q1 | rvmd |
Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
|
740000 | |
CY2020Q1 | rvmd |
Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
|
645000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1171000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-287000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1257000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
3202000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-2131000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-3084000 | |
CY2021Q1 | rvmd |
Vesting Of Early Exercised Options And Restricted Stock
VestingOfEarlyExercisedOptionsAndRestrictedStock
|
46000 | |
CY2020Q1 | rvmd |
Vesting Of Early Exercised Options And Restricted Stock
VestingOfEarlyExercisedOptionsAndRestrictedStock
|
47000 | |
CY2021Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
882000 | |
CY2020Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
37000 | |
CY2021Q1 | rvmd |
Unpaid Offering Costs
UnpaidOfferingCosts
|
564000 | |
CY2020Q1 | rvmd |
Unpaid Offering Costs
UnpaidOfferingCosts
|
1417000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
1200000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-963000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-2493000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-3033000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
716000 | |
CY2021Q1 | rvmd |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-670000 | |
CY2020Q1 | rvmd |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-775000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
853000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-19000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-37246000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-28018000 | |
CY2021Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
114038000 | |
CY2020Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
100038000 | |
CY2021Q1 | rvmd |
Proceeds From Maturity Of Marketable Securities
ProceedsFromMaturityOfMarketableSecurities
|
119926000 | |
CY2020Q1 | rvmd |
Proceeds From Maturity Of Marketable Securities
ProceedsFromMaturityOfMarketableSecurities
|
40925000 | |
CY2021Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3579000 | |
CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
603000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
2309000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-59716000 | |
CY2021Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
281709000 | |
CY2020Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
253717000 | |
CY2021Q1 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
555000 | |
CY2020Q1 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
27000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
282264000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
253744000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
247327000 | |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
166010000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
105352000 | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
16873000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
352679000 | |
CY2020Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
182669000 | |
CY2021Q1 | us-gaap |
Restricted Cash
RestrictedCash
|
1084000 | |
CY2020Q1 | us-gaap |
Restricted Cash
RestrictedCash
|
214000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
352679000 | |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
182883000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
16972000 | |
CY2021Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
8740000 | |
CY2020Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
8070000 | |
CY2021Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
700000 | |
CY2020Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
600000 | |
CY2021Q1 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
3237000 | |
CY2020Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
7736000 | |
CY2021Q1 | rvmd |
Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
|
15915000 | |
CY2020Q4 | rvmd |
Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
|
10459000 | |
CY2021Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, clinical accruals, valuation of in-process research and development and developed technologies, income taxes, useful lives of property and equipment and intangible assets, impairment of goodwill, and stock-based compensation. The extent to which the COVID-19 pandemic may directly or indirectly impact the Company’s business, financial condition and results of operations is highly uncertain and subject to change. The Company considered the potential impact of the COVID-19 pandemic on its estimates and assumptions and there was not a material impact to the Company’s condensed consolidated financial statements as of and for the three months ended March 31, 2021. Actual results could materially differ from the Company’s estimates, and there may be changes to the estimates in future periods<font style="font-style:italic;">.</font> </p> | |
CY2021Q1 | us-gaap |
Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
|
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Recent accounting pronouncements not yet adopted</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the FASB issued ASU No. 2016-13,<font style="font-style:italic;"> Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments </font>(ASU 2016-13), which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. ASU 2016-13 replaces the existing incurred loss impairment model with an expected loss model. It also eliminates the concept of other-than-temporary impairment and requires credit losses related to available-for-sale debt securities to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. These changes will result in earlier recognition of credit losses. In November 2018, the FASB issued ASU No. 2018-19, <font style="font-style:italic;">Codification Improvements to Topic 326, Financial Instruments—Credit Losses</font> (ASU 2018-19) which narrowed the scope and changed the effective date for non-public entities for ASU 2016-13. The FASB subsequently issued supplemental guidance within ASU No. 2019-05,<font style="font-style:italic;"> Financial Instruments—Credit Losses (Topic 326): Targeted Transition Relief </font>(ASU 2019-05). ASU 2019-05 provides an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. ASU 2016-13 is applicable to the Company for the fiscal year beginning after December 15, 2021. Early adoption is permitted. The Company is currently evaluating the impact the adoption of these ASUs will have on its consolidated financial statements and related disclosures. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2018, the FASB issued ASU No. 2018-15, <font style="font-style:italic;">Intangibles—Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</font> (ASU 2018-15). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use-software. This ASU is effective for the Company for the fiscal year beginning after December 15, 2020, and interim periods within fiscal years beginning after December 31, 2021. The Company is currently evaluating the impact of this ASU on the Company’s consolidated financial statements. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2020, the FASB issued ASU 2020-08, <font style="font-style:italic;">Codification Improvements to Subtopic 310-20, Receivables-Nonrefundable Fees and Other Costs</font> (ASU 2020-08). This ASU clarifies that an entity should reevaluate whether a callable debt security is within the scope of ASC paragraph 310-20-35-33 for each reporting period. The guidance is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021. Early application is not permitted. All entities should apply ASU 2020-08 on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable debt securities. The Company is currently evaluating the impact of ASU 2020-08 on the Company’s consolidated financial statements.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2020, FASB issued ASU 2020-10, <font style="font-style:italic;">Codification Improvements </font>(ASU 2020-10). This update contains amendments that improve the consistency of the Codification by including all disclosure guidance in the appropriate Disclosure Section (Section 50). Many of the amendments arose because the Board provided an option to give certain information either on the face of the financial statements or in the notes to financial statements and that option only was included in the Other Presentation Matters Section (Section 45) of the Codification. The option to disclose information in the notes to financial statements should have been codified in the Disclosure Section as well as the Other Presentation Matters Section (or other Section of the Codification in which the option to disclose in the notes to financial statements appears). The amendments in this Update do not change GAAP and, therefore, are not expected to result in a significant change in practice. The amendments are effective for the Company for fiscal years beginning after December 15, 2021, including interim period within those fiscal years. Early adoption is permitted. Adoption shall be applied retrospectively. The Company is currently evaluating the impacts of the provisions of ASU 2020-10 on its consolidated financial statements and related disclosures.</p> | |
CY2020Q1 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.2055 | |
CY2020Q1 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1-for-4.8661 | |
CY2021Q1 | rvmd |
Fair Value Level1 Level2 Level3 Transfers Amount
FairValueLevel1Level2Level3TransfersAmount
|
0 | |
CY2020Q4 | rvmd |
Fair Value Level1 Level2 Level3 Transfers Amount
FairValueLevel1Level2Level3TransfersAmount
|
0 | |
CY2021Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
682198000 | |
CY2021Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
91000 | |
CY2021Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
28000 | |
CY2021Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
682261000 | |
CY2020Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
441963000 | |
CY2020Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
131000 | |
CY2020Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
15000 | |
CY2020Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
442079000 | |
CY2021Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
19619000 | |
CY2021Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1189000 | |
CY2020Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
492000 | |
CY2021Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
104000 | |
CY2020Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
97000 | |
CY2021Q1 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
55800000 | |
CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
7480000 | |
CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2602000 | |
CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
4878000 | |
CY2021Q1 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P4Y7M6D | |
CY2021Q1 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
63280000 | |
CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
801000 | |
CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
1069000 | |
CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
1069000 | |
CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
1069000 | |
CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
870000 | |
CY2020Q4 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
55800000 | |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
7480000 | |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2335000 | |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
5145000 | |
CY2020 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P4Y9M18D | |
CY2020Q4 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
63280000 | |
CY2021Q1 | us-gaap |
Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
|
0 | |
CY2021Q1 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | |
CY2021Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
31994000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
32664000 | |
CY2020Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
19000 | |
CY2020Q4 | us-gaap |
Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
rvmd:AccruedResearchAndDevelopmentExpenseCurrent | |
CY2020Q4 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
19000 | |
CY2021Q1 | rvmd |
Lease Liabilities
LeaseLiabilities
|
31994000 | |
CY2020Q4 | rvmd |
Lease Liabilities
LeaseLiabilities
|
32683000 | |
CY2021Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
800000 | |
CY2020Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
400000 | |
CY2021Q1 | us-gaap |
Sublease Income
SubleaseIncome
|
600000 | |
CY2020Q1 | us-gaap |
Sublease Income
SubleaseIncome
|
400000 | |
CY2021Q1 | rvmd |
Tenant Improvement Allowance Credits
TenantImprovementAllowanceCredits
|
100000 | |
CY2020Q1 | rvmd |
Tenant Improvement Allowance Credits
TenantImprovementAllowanceCredits
|
100000 | |
CY2021Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
700000 | |
CY2020Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
800000 | |
CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
3454000 | |
CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
5144000 | |
CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
4173000 | |
CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
4215000 | |
CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
4363000 | |
CY2021Q1 | rvmd |
Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
|
24213000 | |
CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
45562000 | |
CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
12264000 | |
CY2021Q1 | rvmd |
Lessee Operating Lease Liability Tenant Improvement Allowance
LesseeOperatingLeaseLiabilityTenantImprovementAllowance
|
1304000 | |
CY2021Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.071 | |
CY2020Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.071 | |
CY2021Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P8Y10M24D | |
CY2020Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P9Y1M6D | |
CY2021Q1 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
0 | |
CY2020Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
0 | |
CY2021Q1 | us-gaap |
Common Stock Voting Rights
CommonStockVotingRights
|
Each share of common stock is entitled to one vote | |
CY2021Q1 | rvmd |
Number Of Voting Rights Per Common Share
NumberOfVotingRightsPerCommonShare
|
1 | |
CY2021Q1 | us-gaap |
Dividends Common Stock
DividendsCommonStock
|
0 | |
CY2021Q1 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
14338545 | |
CY2020Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
10511256 | |
CY2021Q1 | rvmd |
Shares Of Common Stock Subject To Repurchase
SharesOfCommonStockSubjectToRepurchase
|
95936 | |
CY2020Q4 | rvmd |
Shares Of Common Stock Subject To Repurchase
SharesOfCommonStockSubjectToRepurchase
|
130793 | |
CY2021Q1 | rvmd |
Exercise Price Of Early Exercised Shares Of Common Stock
ExercisePriceOfEarlyExercisedSharesOfCommonStock
|
200000 | |
CY2020Q4 | rvmd |
Exercise Price Of Early Exercised Shares Of Common Stock
ExercisePriceOfEarlyExercisedSharesOfCommonStock
|
200000 | |
CY2021Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
46300000 | |
CY2021Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y8M12D | |
CY2021Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3387000 | |
CY2020Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1567000 | |
CY2021Q1 | rvmd |
Weighted Average Number Of Shares Issued Basic And Diluted
WeightedAverageNumberOfSharesIssuedBasicAndDiluted
|
70534554 | |
CY2020Q1 | rvmd |
Weighted Average Number Of Shares Issued Basic And Diluted
WeightedAverageNumberOfSharesIssuedBasicAndDiluted
|
29616684 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
|
114478 | |
CY2020Q1 | us-gaap |
Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
|
318986 | |
CY2021Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6434432 | |
CY2020Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5860704 |